NYSE:TDOC

Teladoc Health Stock Forecast, Price & News

$182.01
+0.75 (+0.41 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$176.26
Now: $182.01
$183.75
50-Day Range
$171.30
MA: $197.31
$292.51
52-Week Range
$147.71
Now: $182.01
$308.00
Volume1.96 million shs
Average Volume3.60 million shs
Market Capitalization$27.79 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.3
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002 by George Byron Brooks and is headquartered in Purchase, NY.
Teladoc Health logo

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone(203) 635-2002
Employees3,276
Year Founded2002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$553.31 million
Book Value$14.01 per share

Profitability

Net Income$-98,860,000.00

Miscellaneous

Market Cap$27.79 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable

Headlines

LifeMD Stock is a Leveraged Telehealth Play (TDOC)
March 18, 2021 |  marketbeat.com
Teladoc Health is Now Oversold (TDOC)
April 7, 2021 |  nasdaq.com
3 Unstoppable Stocks to Buy for a Biden Bull Market
April 1, 2021 |  finance.yahoo.com
Teladoc Health Stock Appears To Be Modestly Overvalued
March 31, 2021 |  finance.yahoo.com
Cathie Wood Is Buying Teladoc. Should You?
March 31, 2021 |  finance.yahoo.com
TDOC May 7th Options Begin Trading
March 25, 2021 |  nasdaq.com
Teladoc Health (NYSE:TDOC) Stock Price Down 4.1%
March 25, 2021 |  americanbankingnews.com
Got $500? 3 Undisruptable Stocks to Buy Right Now
March 24, 2021 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

1.69 out of 5 stars

Medical Sector

282nd out of 2,016 stocks

Offices & Clinics Of Medical Doctors Industry

2nd out of 8 stocks

Analyst Opinion: 4.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
$182.01
+0.75 (+0.41 %)
(As of 04/12/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teladoc Health (NYSE:TDOC) Frequently Asked Questions

Is Teladoc Health a buy right now?

31 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 18 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Teladoc Health stock.
View analyst ratings for Teladoc Health
or view top-rated stocks.

What stocks does MarketBeat like better than Teladoc Health?

Wall Street analysts have given Teladoc Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Teladoc Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Teladoc Health?

Teladoc Health saw a increase in short interest in March. As of March 31st, there was short interest totaling 15,820,000 shares, an increase of 27.4% from the March 15th total of 12,420,000 shares. Based on an average daily volume of 3,640,000 shares, the short-interest ratio is presently 4.3 days.
View Teladoc Health's Short Interest
.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Teladoc Health
.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) issued its quarterly earnings results on Wednesday, February, 24th. The health services provider reported ($3.07) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.25) by $2.82. Teladoc Health had a negative net margin of 12.71% and a negative trailing twelve-month return on equity of 6.15%.
View Teladoc Health's earnings history
.

How has Teladoc Health's stock been impacted by Coronavirus (COVID-19)?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TDOC shares have increased by 32.5% and is now trading at $182.01.
View which stocks have been most impacted by COVID-19
.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health updated its FY 2021 After-Hours earnings guidance on Wednesday, February, 24th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.95-2 billion, compared to the consensus revenue estimate of $1.95 billion.

What price target have analysts set for TDOC?

31 brokers have issued 1 year price targets for Teladoc Health's stock. Their forecasts range from $165.00 to $330.00. On average, they expect Teladoc Health's stock price to reach $243.00 in the next year. This suggests a possible upside of 33.5% from the stock's current price.
View analysts' price targets for Teladoc Health
or view top-rated stocks among Wall Street analysts.

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:
  • Jason N. Gorevic, Chief Executive Officer & Director (LinkedIn Profile)
  • David William Sides, Chief Operating Officer (LinkedIn Profile)
  • Mala Murthy, Chief Financial Officer (LinkedIn Profile)
  • Jeff Nadler, Chief Information Officer
  • Lewis Levy, Chief Medical Officer

What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health CEO Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among Teladoc Health's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Teladoc Health's key competitors?

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), DocuSign (DOCU), salesforce.com (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

(TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Spence Asset Management (0.06%), Teamwork Financial Advisors LLC (0.02%), Phoenix Wealth Advisors (0.01%), Coastal Investment Advisors Inc. (0.01%), Harbour Capital Advisors LLC (0.00%) and HighPoint Advisor Group LLC (0.00%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete, William H Frist and Yulun Wang.
View institutional ownership trends for Teladoc Health
.

Which major investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Spence Asset Management, Teamwork Financial Advisors LLC, First Hawaiian Bank, Pacer Advisors Inc., Baldwin Brothers Inc. MA, Coastal Investment Advisors Inc., and Huntington National Bank. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Stephany Verstraete, William H Frist, and Yulun Wang.
View insider buying and selling activity for Teladoc Health
or view top insider-selling stocks.

Which major investors are buying Teladoc Health stock?

TDOC stock was purchased by a variety of institutional investors in the last quarter, including Harbour Capital Advisors LLC, Phoenix Wealth Advisors, Paragon Advisors LLC, Valeo Financial Advisors LLC, HighPoint Advisor Group LLC, Winfield Associates Inc., Carnegie Capital Asset Management LLC, and EFG Asset Management Americas Corp..
View insider buying and selling activity for Teladoc Health
or or view top insider-buying stocks.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $182.01.

How much money does Teladoc Health make?

Teladoc Health has a market capitalization of $27.79 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis.

How many employees does Teladoc Health have?

Teladoc Health employs 3,276 workers across the globe.

Does Teladoc Health have any subsidiaries?

The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..

When was Teladoc Health founded?

Teladoc Health was founded in 2002.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladochealth.com.

Where are Teladoc Health's headquarters?

Teladoc Health is headquartered at 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at (203) 635-2002 or via email at [email protected]


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.